279 related articles for article (PubMed ID: 24021907)
1. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Reagan P; Pani A; Rosner MH
Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
[TBL] [Abstract][Full Text] [Related]
2. [Refractory hypercalcemia in patient with lung cancer].
Grzywacz A; Dziuk M; Niemczyk S
Pol Merkur Lekarski; 2014 Apr; 36(214):261-4. PubMed ID: 24868900
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
4. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
5. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
7. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
Kovacs CS; MacDonald SM; Chik CL; Bruera E
J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
[TBL] [Abstract][Full Text] [Related]
9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
10. Cancer-induced hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
12. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
13. A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α).
Shimizu H; Monden T; Tomotsune T; Nakatani Y; Domeki N; Matsumura M; Jojima T; Kawagoe Y; Kasai K
Intern Med; 2011; 50(24):2993-6. PubMed ID: 22185991
[TBL] [Abstract][Full Text] [Related]
14. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
15. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related peptide as a cause of hypercalcemia in squamous cell carcinoma of the head and neck: a case presentation and subject review.
Brawner JT; Zitsch RP
Head Neck; 2004 Apr; 26(4):382-4. PubMed ID: 15054743
[TBL] [Abstract][Full Text] [Related]
17. Secretion of parathyroid hormone-related peptide in patients with multiple myeloma.
Beaudreuil J; Cohen-Solal M; Doré MX; Vernejoul MC; Bardin T; Celton N; Giraudeaux V; Kuntz D
Rev Rhum Engl Ed; 1996; 63(7-8):502-3. PubMed ID: 8896065
[TBL] [Abstract][Full Text] [Related]
18. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignancy associated hypercalcemia].
Tai N; Inoue D
Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
[TBL] [Abstract][Full Text] [Related]
20. Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia.
Martens P; Addissie B; Kumar R
Acta Clin Belg; 2015 Jun; 70(3):200-3. PubMed ID: 25475431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
